BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 17073644)

  • 1. Generation and maintenance of mucosal memory B cell responses?
    Vajdy M
    Curr Med Chem; 2006; 13(25):3023-37. PubMed ID: 17073644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of adjuvants in the development of mucosal vaccines.
    Vajdy M; Singh M
    Expert Opin Biol Ther; 2005 Jul; 5(7):953-65. PubMed ID: 16018740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of long term mucosal immunological memory in humans by an oral inactivated multivalent enterotoxigenic Escherichia coli vaccine.
    Lundgren A; Jertborn M; Svennerholm AM
    Vaccine; 2016 Jun; 34(27):3132-3140. PubMed ID: 27133878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BAFF, stimulatory DNA and IL-15 stimulates IgA(+) memory B cells and provides a novel approach for analysis of memory responses to mucosal vaccines.
    Tengvall S; Lundgren A; Quiding-Järbrink M; Svennerholm AM
    Vaccine; 2010 Jul; 28(33):5445-50. PubMed ID: 20547203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. B cell and T cell immunity in the female genital tract: potential of distinct mucosal routes of vaccination and role of tissue-associated dendritic cells and natural killer cells.
    Anjuère F; Bekri S; Bihl F; Braud VM; Cuburu N; Czerkinsky C; Hervouet C; Luci C
    Clin Microbiol Infect; 2012 Oct; 18 Suppl 5():117-22. PubMed ID: 22882377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel vaccine development strategies for inducing mucosal immunity.
    Fujkuyama Y; Tokuhara D; Kataoka K; Gilbert RS; McGhee JR; Yuki Y; Kiyono H; Fujihashi K
    Expert Rev Vaccines; 2012 Mar; 11(3):367-79. PubMed ID: 22380827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Innate endogenous adjuvants prime to desirable immune responses via mucosal routes.
    Wang X; Meng D
    Protein Cell; 2015 Mar; 6(3):170-84. PubMed ID: 25503634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mucosal vaccines: a paradigm shift in the development of mucosal adjuvants and delivery vehicles.
    Srivastava A; Gowda DV; Madhunapantula SV; Shinde CG; Iyer M
    APMIS; 2015 Apr; 123(4):275-88. PubMed ID: 25630573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcutaneous immunization with novel lipid-based adjuvants induces protection against gastric Helicobacter pylori infection.
    Hickey DK; Aldwell FE; Tan ZY; Bao S; Beagley KW
    Vaccine; 2009 Nov; 27(50):6983-90. PubMed ID: 19800441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nasal immunization of mice with AFCo1 or AFPL1 plus capsular polysaccharide Vi from Salmonella typhi induces cellular response and memory B and T cell responses.
    Romeu B; Lastre M; Reyes L; González E; Borrero Y; Lescaille D; Pérez R; Nuñez D; Pérez O
    Vaccine; 2014 Dec; 32(51):6971-6978. PubMed ID: 25454865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Jump-starting the immune system: prime-boosting comes of age.
    Woodland DL
    Trends Immunol; 2004 Feb; 25(2):98-104. PubMed ID: 15102369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mucosal adjuvants and long-term memory development with special focus on CTA1-DD and other ADP-ribosylating toxins.
    Lycke N; Bemark M
    Mucosal Immunol; 2010 Nov; 3(6):556-66. PubMed ID: 20844480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of mucosal immunity through systemic immunization: Phantom or reality?
    Su F; Patel GB; Hu S; Chen W
    Hum Vaccin Immunother; 2016 Apr; 12(4):1070-9. PubMed ID: 26752023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural killer T cell and TLR9 agonists as mucosal adjuvants for sublingual vaccination with clade C HIV-1 envelope protein.
    Singh S; Yang G; Byrareddy SN; Barry MA; Sastry KJ
    Vaccine; 2014 Dec; 32(51):6934-6940. PubMed ID: 25444819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mucosal delivery of vaccine antigens and its advantages in pediatrics.
    De Magistris MT
    Adv Drug Deliv Rev; 2006 Apr; 58(1):52-67. PubMed ID: 16516335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can mucosal adjuvants contribute to the induction of immunological memory induced via unconjugated T-cell-independent antigens?
    Romeu B; Gonzalez E; Lastre M; Pérez O
    J Drug Target; 2012 Jul; 20(6):502-8. PubMed ID: 22632258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of secretory immunity and memory at mucosal surfaces.
    Brandtzaeg P
    Vaccine; 2007 Jul; 25(30):5467-84. PubMed ID: 17227687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunity in response to particulate antigen-delivery systems.
    Storni T; Kündig TM; Senti G; Johansen P
    Adv Drug Deliv Rev; 2005 Jan; 57(3):333-55. PubMed ID: 15560945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Memory control by the B cell antigen receptor.
    Engels N; Wienands J
    Immunol Rev; 2018 May; 283(1):150-160. PubMed ID: 29664567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mucosal adjuvants and delivery systems for protein-, DNA- and RNA-based vaccines.
    Vajdy M; Srivastava I; Polo J; Donnelly J; O'Hagan D; Singh M
    Immunol Cell Biol; 2004 Dec; 82(6):617-27. PubMed ID: 15550120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.